RETROVIRAL ANTI-SENSE RNA--CELLULAR AND VIRAL RESPONSES
逆转录病毒反义 RNA——细胞和病毒反应
基本信息
- 批准号:3191387
- 负责人:
- 金额:$ 17.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-07-01 至 1993-06-30
- 项目状态:已结题
- 来源:
- 关键词:RNA biosynthesis Retroviridae Retroviridae disease actins antisense nucleic acid gene expression genetic transcription genetic translation messenger RNA nucleic acid probes nucleic acid sequence oncogenes oncogenic virus polysomes tissue /cell culture transposon /insertion element virus RNA virus genetics virus infection mechanism virus replication
项目摘要
Anti-sense RNA provides a means for specifically blocking the
expression of a given gene through formation of a duplex with the
target RNA. This technique has also been used to block
replication of retroviruses containing RNA complementary to
cellular RNA. Thus, this technique offers a potential therapeutic
strategy for specifically blocking expression of an oncogenic viral
gene product and/or replication of an oncogenic retrovirus. Use
of this technology, however, has been limited because the
mechanisms by which complementary RNA blocks gene expression
or retroviral replication are poorly understood. A better
understanding of mechanisms by which anti-sense RNA blocks
gene expression and retroviral replication may permit more
effective applications of this technology. A model system using
retroviral vectors capable of expressing RNA complementary to
cellular sequences has been developed. Vectors producing RNA
complementary to different regions of the same target mRNA
have been isolated. Those vectors producing anti-sense
transcripts which are effective in blocking expression of the
target mRNA are approximately 100 x more potent than many
previously reported, they are complementary to a region of the
mRNA which has previously not been considered to be a good
target, and they apparently block expression of the
complementary mRNA by a mechanism which has not been
described previously. The purpose of this proposal is to exploit
this model to define the mechanism(s) by which this anti-sense
system blocks expression of its compementary cellular mRNA and
to determine what effect the complementary cellular RNA has on
replication of the retrovirus. Studies are described in which a
series of retroviral constructs will be used to 1) define more
precisely the regions of the complementary RNAs participating in
duplex formation in vivo and in vitro, 2) effects of different RNA
transcripts upon duplex formation and stability, and 3)
mechanisms by which effective anti-sense constructs block
translation of complementary cellular mRNA's. Experiments
using this same model are described which will address the
following questions: 1) Are cells which produce RNA
complementary to that of the retrovirus less susceptible to
infection by this retrovirus? If so, what factors affect the extent
of this resistance? 2) Do complementary cellular RNAs adversely
affect packaging and release of viruses capable of infecting other
cells?
反义RNA提供了一种专门阻断
通过与基因形成双链来表达某一特定基因
靶向RNA。这项技术也被用来阻止
复制含有互补的RNA的逆转录病毒
细胞核糖核酸。因此,这项技术提供了一种潜在的治疗方法
特异性阻断致癌病毒表达的策略
致癌逆转录病毒的基因产物和/或复制。使用
然而,这项技术的应用一直受到限制,因为
互补RNA阻断基因表达的机制
或逆转录病毒复制,人们对此知之甚少。更好的
对反义RNA阻断机制的理解
基因表达和逆转录病毒复制可能允许更多
这项技术的有效应用。一个模型系统,使用
能够表达互补的RNA的逆转录病毒载体
细胞序列已经被开发出来。产生RNA的载体
互补于同一靶基因的不同区域
已经被隔离了。那些产生反义的载体
能有效阻断基因表达的转录本
靶基因的效力大约是许多基因的100倍。
此前报道,它们是对一个地区的补充
以前并不被认为是好的
目标,而且它们显然阻止了
通过一种尚未被发现的机制来补充mRNA
如前所述。这项提议的目的是利用
这个模型来定义这个反义的机制(S
系统阻断其组成细胞的mRNA和
为了确定互补的细胞RNA对
逆转录病毒的复制。描述了一项研究,其中
一系列逆转录病毒构建物将用于1)定义更多
准确地说,参与的互补RNA的区域
体内和体外双链形成,2)不同RNA的作用
关于双链形成和稳定性的抄本,以及3)
有效反义构建阻断的机制
互补细胞基因的翻译。实验
使用相同的模型进行了描述,这将解决
以下问题:1)是产生RNA的细胞吗?
与不易感染的逆转录病毒互补
被这种逆转录病毒感染?如果是这样,是什么因素影响了这一程度
这种抗性?2)对互补的细胞RNA产生不利影响
影响能够感染他人的病毒的包装和释放
细胞?
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reversal of creatine kinase translational repression by 3' untranslated sequences.
3非翻译序列逆转肌酸激酶翻译抑制。
- DOI:10.1126/science.2343304
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Ch'ng,JL;Shoemaker,DL;Schimmel,P;Holmes,EW
- 通讯作者:Holmes,EW
Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo.
与肌酸激酶 3 编码和非编码序列互补的反义 RNA 是体内翻译的有效抑制剂。
- DOI:10.1073/pnas.86.24.10006
- 发表时间:1989
- 期刊:
- 影响因子:11.1
- 作者:Ch'ng,JL;Mulligan,RC;Schimmel,P;Holmes,EW
- 通讯作者:Holmes,EW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD W HOLMES其他文献
EDWARD W HOLMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD W HOLMES', 18)}}的其他基金
GENERAL CLINICAL RESEARCH CENTER: BIRN, NEUROIMAGING
一般临床研究中心:BIRN,神经影像
- 批准号:
7205540 - 财政年份:2003
- 资助金额:
$ 17.37万 - 项目类别:
GENERAL CLINICAL RESEARCH CENTER: BIRN, NEUROIMAGING
一般临床研究中心:BIRN,神经影像
- 批准号:
7045359 - 财政年份:2003
- 资助金额:
$ 17.37万 - 项目类别: